Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPO Deal Infuses Braun’s I.V. Catheter Segment; Medex, BD Share Targeted

This article was originally published in The Gray Sheet

Executive Summary

B. Braun expects a three-year, multisource agreement with Premier to propel sales growth for intravascular safety catheters heading into 2005

You may also be interested in...



Smiths Medical Buys Medex to Fill I.V. Catheter Gap in Safety Devices Line

Smiths Medical gains intravenous catheters absent from its existing safety-engineered devices line-up via the purchase of privately held Medex for $925 mil. in cash and debt

Smiths Medical Buys Medex to Fill I.V. Catheter Gap in Safety Devices Line

Smiths Medical gains intravenous catheters absent from its existing safety-engineered devices line-up via the purchase of privately held Medex for $925 mil. in cash and debt

Medex’ Purchase Of J&J Vascular Access Expected To Close By June

Medex will leverage the brand recognition of Ethicon Endo-Surgery Vascular Access' intravenous catheters to bolster its existing fluid and drug delivery systems

Related Content

UsernamePublicRestriction

Register

MT021211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel